Search in:

The Application of Clinical Genetics Volume 14, 2021 - Issue

Submit an article Journal homepage

Open access

283

Views

CrossRef citations to date

Altmetric

Review

Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers

Lindsey McAlarnenDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA

https://orcid.org/0000-0002-5020-6774

Kristen StearnsDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA

https://orcid.org/0000-0002-3634-0758

Denise UyarDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USACorrespondence[email protected]

Pages 1-9 | Published online: 14 Jan 2021

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (9)

Samantha Pollard, Deirdre Weymann, Rosalie Loewen, Jennifer Nuk, Sophie Sun, Kasmintan A. Schrader, Chiquita Hessels & Dean A. Regier. (2023) Development and early‐stage evaluation of a patient portal to enhance familial communication about hereditary cancer susceptibility testing: A patient‐driven approach. Health Expectations 26:2, pages 774-784.
Crossref

Marcella Nunziato, Giovanni Luca Scaglione, Federica Di Maggio, Carmela Nardelli, Ettore Capoluongo & Francesco Salvatore. (2023) The performance of multi-gene panels for breast/ovarian cancer predisposition. Clinica Chimica Acta 539, pages 151-161.
Crossref

Christine B. Weldon, Julia R. Trosman, Su‐Ying Liang, Michael P. Douglas, Maren T. Scheuner, Allison Kurian, Kendra L. Schaa, Breanna Roscow, Deanna Erwin & Kathryn A. Phillips. (2022) Genetic counselors' experience with reimbursement and patient out‐of‐pocket cost for multi‐cancer gene panel testing for hereditary cancer syndromes. Journal of Genetic Counseling 31:6, pages 1394-1403.
Crossref

Anna Doraczynska-Kowalik, Dagmara Michalowska, Rafal Matkowski, Ewelina Czykalko, Dorota Blomka, Mariola Semeniuk, Mariola Abrahamowska, Gabriela Janus-Szymanska, Paulina Mlynarczykowska, Bartlomiej Szynglarewicz, Ireneusz Pawlak, Adam Maciejczyk & Izabela Laczmanska. (2022) Detection of BRCA1/2 pathogenic variants in patients with breast and/or ovarian cancer and their families. Analysis of 3,458 cases from Lower Silesia (Poland) according to the diagnostic algorithm of the National Cancer Control Programme. Frontiers in Genetics 13.
Crossref

Marcella Nunziato, Federica Di Maggio, Matilde Pensabene, Maria Valeria Esposito, Flavio Starnone, Carmine De Angelis, Alessandra Calabrese, Massimiliano D’Aiuto, Gerardo Botti, Sabino De Placido, Valeria D’Argenio & Francesco Salvatore. (2022) Multi-gene panel testing increases germline predisposing mutations’ detection in a cohort of breast/ovarian cancer patients from Southern Italy. Frontiers in Medicine 9.
Crossref

Arian Mansur, Fang Zhang & Christine Y. Lu. (2022) Association between Health Insurance Type and Genetic Testing and/or Counseling for Breast and Ovarian Cancer. Journal of Personalized Medicine 12:8, pages 1263.
Crossref

Lara Sanoguera-Miralles, Elena Bueno-Martínez, Alberto Valenzuela-Palomo, Ada Esteban-Sánchez, Inés Llinares-Burguet, Pedro Pérez-Segura, Alicia García-Álvarez, Miguel de la Hoya & Eladio A. Velasco-Sampedro. (2022) Minigene Splicing Assays Identify 20 Spliceogenic Variants of the Breast/Ovarian Cancer Susceptibility Gene RAD51C. Cancers 14:12, pages 2960.
Crossref

Suzanne C. O’Neill, Jada G. Hamilton, Claire C. Conley, Beth N. Peshkin, Rosalba Sacca, Glynnis A. McDonnell, Claudine Isaacs, Mark E. Robson & Kenneth P. Tercyak. (2021) Improving our model of cascade testing for hereditary cancer risk by leveraging patient peer support: a concept report. Hereditary Cancer in Clinical Practice 19:1.
Crossref

Camille Franchet, Jean-Sébastien Hoffmann & Florence Dalenc. (2021) Recent Advances in Enhancing the Therapeutic Index of PARP Inhibitors in Breast Cancer. Cancers 13:16, pages 4132.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers

Articles from other publishers (9)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Challenges of Genomic Testing for Hereditary Breast and Ovarian Cancers

Citations (9)

Articles from other publishers (9)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date